肾素抑制剂阿利吉仑治疗高血压的现状
摘要
目的综述肾素抑制剂阿利吉仑抗高血压药的现状。方法参阅相关文献,从一般介绍、药理学、临床试验、临床评价、不良反应和注意事项等对阿利吉仑治疗高血压的现状进行综述。结果与结论阿利吉仑对轻中度高血压有明显的疗效,可与其他抗高血压药联用;对其不良反应及学术观点的不同意见应予关注。
出处
《中国药学杂志》
CAS
CSCD
北大核心
2008年第21期1604-1607,共4页
Chinese Pharmaceutical Journal
参考文献17
-
1李华,郭冀珍.阿利吉仑——一种新型肾素抑制剂[J].中国新药与临床杂志,2006,25(3):216-219. 被引量:5
-
2ZHANGAL DUXL.Novel antihypertensive drug:aliskiren .中国约学杂志,2008,43(3):237-238.
-
3GRADMAN A H,KAD B. Renin inhibition in hypertension[J]. Am Coll Cardiol,2008,51 (5) :519-528.
-
4Novartis Pharmaceuticals Corporation : Tekturna( aliskiren ) [ R ]. NDA21-985, February ,2007 ( T2007-05 ) ( T2007-06 ).
-
5GRADMAN A, KOLLOCH R E, MYERS M,et al. Aliskiren in combination with hydrochlorothiazide is effective and well tolerated during long-termtreatment of hypertension [ J ]. J Clin Hypertens,2007,9 ( 5 suppl A ) : 160.
-
6KUSHURO T,ITAKURA H, ABO Y,et al. Long-term safety and efficacy of aliskiren, an oral direct renin inhibitor,in Japanese patients with hypertension [ J]. J Clin ttypertens,2007,9 (5 Suppl A) :169.
-
7OH B H, MITCHELL J,HERREON J R, et al. Aliskiren,an oral renin inhibitor, provides dose-dependent efficacy and sustained 24 h blood pressure control in patients. With hypertension [ J ]. J Am Coll Cardiol, 2007,49 ( 11 ) : 1157-1163.
-
8VAIDYANATHAN S,REYNOLDS C,YEH C M, et al, Pharmacokinetics,Safety,and Tolerability of the novel oral direct rennin inhibitor aliskiren in olderly healthy subjects[ J]. J Clin Pharmacol ,2007,47 (4) :453-460.
-
9ZHAO C,VAIDYANATHAN S, YEH C M,et al. Aliskiren exhibits similar pbarmacokineties in healthy volunteers and patients with type 2 diabetes mellitus [ J ]. Clin Pharmacokinet, 2006,45 (11) :1125-1134.
-
10URESIN Y,TAYLOR A,KILO C,et al. Aliskiren,a novel rennin inhibitor, has greater BPlowering than ramipril and additional BPlowering when combined with ramipril in patients with diabetes and hypertension [J]. J Hypertens,2006,24 ( Suppl 4 ) : 82.
二级参考文献11
-
1DZAU V.The cardiovascular continuum and renin-angiotensin-aldosterone system blockade[J].J Hypertens Suppl,2005,23 (1):S9-S17.
-
2WOOD JM,MAIBAUM J,RAHUEL J,et al.Structure-based design of aliskiren,a novel orally effective renin inhibitor[J].Biochem Biophys Res Commun,2003,308(4):698-705.
-
3SICA DA.Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy:its role in clinical practice[J].J Clin Hypertens,2003,5(6):414-420.
-
4HOLLENBERG NK,FISHER NDL,PRICE DA.Pathways for angiotensin Ⅱ generation in intact human tissue:evidence from comparative pharmacological interruption of the renin system[J].Hypertension,1998,32(3):387-392.
-
5AZIZI M,MENARD J,BISSERY A,et al.Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin Ⅱ-renin feedback interruption[J].J Am Soc Nephrol,2004,15(12):3126-3133.
-
6DIETERLE W,CORYNEN S,MANN J.Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects[J].Br J Clin Pharmacol,2004,58(4):433-436.
-
7HOLLENBERG NK.Angiotensin Ⅱ suppression in humans by the orally active renin inhibitor aliskiren (SPP100).Comparison with enalapril[J].Curr Hypertens Rep,2002,4(4):269-270.
-
8WOOD JM,SCHNELL CR,CUMIN F,et al.Aliskiren,a novel,orally effective renin inhibitor,lowers blood pressure in marmosets and spontaneously hypertensive rats[J].J Hypertens,2005,23(2):417-426.
-
9STANTON A,JENSEN C,NUSSBERGER J,et al.Blood pressure lowering in essential hypertension with an oral renin inhibitor,aliskiren[J].Hypertension,2003,42(6):1137-1143.
-
10PILZ B,SHAGDARSUREN E,WELLNER M,et al.Aliskiren,a human renin inhibitor,ameliorates cardiac and renal damage in double-transgenic rats[J].Hypertension,2005,46(3):569-576.
共引文献4
-
1贾晓燕,赵秀丽.肾素抑制剂的研究进展[J].中国新药杂志,2009,18(11):992-994. 被引量:1
-
2胡晓娜,刘方,保志军.直接肾素抑制剂阿利吉仑的药理作用及临床应用研究进展[J].中国临床药学杂志,2011,20(6):387-390.
-
3段自田,韦应社.肾素抑制剂治疗高血压的研究进展[J].实用心脑肺血管病杂志,2012,20(6):946-947. 被引量:8
-
4杨宏彬.阿利吉仑联合依那普利治疗轻中度原发性高血压病的疗效及安全性观察[J].临床合理用药杂志,2016,9(18):55-57.
-
1赵英英,孔霞,张洋.对《抗菌药物临床应用指导原则(2015年版)》的不同意见[J].中国医药生物技术,2016,11(6):567-568. 被引量:5
-
2徐振强.低分子肝素治疗急性脑梗死42例临床观察[J].广西医科大学学报,2002,19(3):425-426. 被引量:1
-
3谭兴春.北京降压0号治疗高血压病的再评价[J].中华临床内科杂志,2004,12(1):789-790.
-
4刘久红,杨娟.青霉素过敏史者能否再用该类药物[J].中华医药学杂志,2003,2(11):2-3.
-
5景相林.对撤销县级药检所的不同意见[J].中国农村卫生事业管理,1999,19(3):21-22.
-
6韩文斌,宋运琴.MAC的临床研究进展[J].国外医学(麻醉学与复苏分册),1996,17(5):303-307. 被引量:6
-
7何世华.维生素E与化学物质的毒性作用[J].国外医学(卫生学分册),1995,22(6):330-333. 被引量:2
-
8黎国栋,吴洪文.药师在全肠外营养液处方干预中的作用[J].中国医药指南,2016,14(1):107-108. 被引量:2
-
9肖国辉,刘玉枝.对《革兰氏阳性球菌的分布及耐药性》一文的商榷[J].中国误诊学杂志,2006,6(9):1731-1731.
-
10雷招宝.头孢曲松与尿路结石[J].药物流行病学杂志,2012,21(1):43-44. 被引量:1